Learn About Important Considerations Before Ocrevus Infusion

Ocrevus, also known as ocrelizumab, is an infusion treatment used for certain forms of multiple sclerosis. Before an infusion, healthcare professionals generally review a person's medical history, current medications, infection status, and previous reactions to medicines. Understanding these considerations can help patients prepare for discussions with their healthcare team and recognize why certain checks may be required before treatment.

Medical History and Health Considerations

Before an Ocrevus infusion, healthcare professionals may review health conditions and previous medical experiences that could affect treatment. This information helps the care team determine whether additional monitoring, testing, or precautions may be appropriate.

Important considerations may include:

• Previous allergic or infusion related reactions to medicines should be discussed with the healthcare professional.
• Current or recent infections should be reported before treatment because Ocrevus affects certain immune cells.
• A history of hepatitis B infection may require specific screening before treatment.
• Existing medical conditions and previous treatments for multiple sclerosis should be reviewed.
• Current prescription medicines, over the counter medicines, and supplements should be disclosed.
• Vaccination history may be discussed because some vaccines may need to be administered before treatment begins.
• Pregnancy plans or pregnancy should be discussed with the healthcare professional so treatment decisions can be considered appropriately.

Patients should not stop prescribed medicines or change their treatment schedule without guidance from their healthcare team. If someone develops symptoms of an infection or feels unwell before a planned infusion, they should contact the treating healthcare provider for advice.

What to Expect Before and During Infusion

Ocrevus is administered intravenously in a healthcare setting. Before administration, healthcare professionals may perform health checks and provide medicines intended to reduce the likelihood or severity of infusion related reactions. The patient may then be monitored during the infusion and for a period afterward.

Some useful points to understand include:

• The healthcare team may check vital signs before and during treatment.
• Premedication may be provided according to the healthcare professional's instructions.
• Infusion related reactions can include itching, rash, headache, throat irritation, flushing, fever, or changes in blood pressure.
• Patients should promptly report unusual symptoms during the infusion.
• Observation after treatment may be required depending on the clinical situation.
• The healthcare team can explain when to seek medical attention after leaving the infusion facility.

Preparation requirements can vary depending on individual health circumstances and the healthcare provider's protocol. Patients should follow the specific instructions given by their treating team rather than relying on general preparation advice.

Ocrevus treatment involves medical considerations that should be evaluated individually. Discussing medical history, infections, vaccinations, medications, and previous treatment experiences with a qualified healthcare professional can help ensure that relevant factors are considered before an infusion. This information is provided for educational purposes only and is not intended to provide medical diagnosis, treatment, sales, or healthcare services.